282 related articles for article (PubMed ID: 29162390)
1. Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression.
Vlodavsky I; Gross-Cohen M; Weissmann M; Ilan N; Sanderson RD
Trends Biochem Sci; 2018 Jan; 43(1):18-31. PubMed ID: 29162390
[TBL] [Abstract][Full Text] [Related]
2. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
[TBL] [Abstract][Full Text] [Related]
3. Heparanase-A single protein with multiple enzymatic and nonenzymatic functions.
Vlodavsky I; Kayal Y; Hilwi M; Soboh S; Sanderson RD; Ilan N
Proteoglycan Res; 2023 Jul; 1(3):e6. PubMed ID: 37547889
[TBL] [Abstract][Full Text] [Related]
4. Role of heparanase in tumor progression: Molecular aspects and therapeutic options.
Masola V; Zaza G; Gambaro G; Franchi M; Onisto M
Semin Cancer Biol; 2020 May; 62():86-98. PubMed ID: 31348993
[TBL] [Abstract][Full Text] [Related]
5. Heparanase inhibitors restrain mesothelioma.
Lapidot M; Barash U; Vlodavsky I; Pass H
Oncotarget; 2018 Dec; 9(96):36830-36832. PubMed ID: 30627323
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior.
Bandari SK; Purushothaman A; Ramani VC; Brinkley GJ; Chandrashekar DS; Varambally S; Mobley JA; Zhang Y; Brown EE; Vlodavsky I; Sanderson RD
Matrix Biol; 2018 Jan; 65():104-118. PubMed ID: 28888912
[TBL] [Abstract][Full Text] [Related]
7. Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer.
Katz A; Barash U; Boyango I; Feld S; Zohar Y; Hammond E; Ilan N; Kremer R; Vlodavsky I
Oncotarget; 2018 Apr; 9(27):19294-19306. PubMed ID: 29721203
[TBL] [Abstract][Full Text] [Related]
8. Significance of host heparanase in promoting tumor growth and metastasis.
Zhang GL; Gutter-Kapon L; Ilan N; Batool T; Singh K; Digre A; Luo Z; Sandler S; Shaked Y; Sanderson RD; Wang XM; Li JP; Vlodavsky I
Matrix Biol; 2020 Nov; 93():25-42. PubMed ID: 32534153
[TBL] [Abstract][Full Text] [Related]
9. Heparanase and cancer progression: New directions, new promises.
Arvatz G; Weissmann M; Ilan N; Vlodavsky I
Hum Vaccin Immunother; 2016 Sep; 12(9):2253-6. PubMed ID: 27054564
[TBL] [Abstract][Full Text] [Related]
10. Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.
Sanderson RD; Elkin M; Rapraeger AC; Ilan N; Vlodavsky I
FEBS J; 2017 Jan; 284(1):42-55. PubMed ID: 27758044
[TBL] [Abstract][Full Text] [Related]
11. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.
Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z
Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400
[TBL] [Abstract][Full Text] [Related]
12. Impact of heparanase-2 (Hpa2) on cancer and inflammation: Advances and paradigms.
Vlodavsky I; Hilwi M; Kayal Y; Soboh S; Ilan N
FASEB J; 2024 May; 38(10):e23670. PubMed ID: 38747803
[TBL] [Abstract][Full Text] [Related]
13. Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes.
Thompson CA; Purushothaman A; Ramani VC; Vlodavsky I; Sanderson RD
J Biol Chem; 2013 Apr; 288(14):10093-10099. PubMed ID: 23430739
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Heparanase in Gastric Cancer Progression and Immunotherapy.
Tang B; Yang S
Adv Exp Med Biol; 2020; 1221():351-363. PubMed ID: 32274717
[TBL] [Abstract][Full Text] [Related]
15. The impact of heparanese and heparin on cancer metastasis and angiogenesis.
Vlodavsky I; Abboud-Jarrous G; Elkin M; Naggi A; Casu B; Sasisekharan R; Ilan N
Pathophysiol Haemost Thromb; 2006; 35(1-2):116-27. PubMed ID: 16855356
[TBL] [Abstract][Full Text] [Related]
16. Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth.
Gross-Cohen M; Feld S; Doweck I; Neufeld G; Hasson P; Arvatz G; Barash U; Naroditsky I; Ilan N; Vlodavsky I
Cancer Res; 2016 May; 76(9):2791-801. PubMed ID: 27013193
[TBL] [Abstract][Full Text] [Related]
17. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
18. Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance.
Lanzi C; Zaffaroni N; Cassinelli G
Curr Med Chem; 2017; 24(26):2860-2886. PubMed ID: 28215163
[TBL] [Abstract][Full Text] [Related]
19. Heparanase: one molecule with multiple functions in cancer progression.
Vlodavsky I; Elkin M; Abboud-Jarrous G; Levi-Adam F; Fuks L; Shafat I; Ilan N
Connect Tissue Res; 2008; 49(3):207-10. PubMed ID: 18661344
[TBL] [Abstract][Full Text] [Related]
20. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
